HLA-DRB1 gene polymorphism is associated with idiopathic dilated cardiomyopathy: A meta-analysis

Journal of Cardiovascular Medicine

Volumn 12, Issue 9, 2011, Pages 648-652

  Deng, Jinlong ^a   Luo, Rong ^b   Li, Xiaoping ^c  

^a PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

HLA DRB1; idiopathic dilated cardiomyopathy; meta analysis

Indexed keywords

HLA DR 0301 ANTIGEN; HLA DR 0901 ANTIGEN; HLA DR 1401 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; CLINICAL RESEARCH; CONGESTIVE CARDIOMYOPATHY; DNA POLYMORPHISM; GENE FREQUENCY; HUMAN; META ANALYSIS; REVIEW;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 80051785617     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328349424b     Document Type: Review

References (35)

1. Michels VV. Progress in defining the causes of idiopathic dilated cardiomyopathy. N Engl J Med 1993; 329:960-961. (Pubitemid 23275281)
2. de Leeuw N, Melchers WJ, Ruiter DJ, et al. Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. J Clin Pathol 1999; 52:739-743. (Pubitemid 29481333)
3. Portig I, Sandmoeller A, Kreilinger S, Maisch B. HLA-DQB1-polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 2009; 42:33-40.
4. Limas CJ, Limas C. HLA-DR antigen linkage of antibeta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy. Br Heart J 1992; 67:402-405.
5. Nishi H, Koga Y, Koyanagi T, et al. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J Mol Cell Cardiol 1995; 27:2385-2392.
6. Rodriguez-Perez JM, Fragoso JM, Alvarez-Leon E, et al. MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy. Exp Mol Pathol 2007; 82:49-52. (Pubitemid 46038276)
7. Carlquist JF, Ward RH, Husebye D, Feolo M, Anderson JL. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74:918-920. (Pubitemid 24340315)
8. Lozano MD, Rubocki RJ, Wilson JE, McManus BM, Wisecarver JL. Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy.Myocarditis treatment trial investigators. J Card Fail 1997; 3:97-103. (Pubitemid 127675013)
9. Mahjoub S, Mehri S, Ghazouani E, et al. HLA class II polymorphisms in Tunisian patients with dilated cardiomyopathy. Tissue Antigens 2010; 75:679-683.
10. Hiroi S, Harada H, Nishi H, Satoh M, Nagai R, Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999; 261:332-339. (Pubitemid 29392477)
11. Luppi P, Alexander A, Bertera S, Noonan K, Trucco M. The same HLA-DQ alleles determine either susceptibility or resistance to different coxsackievirus-mediated autoimmune diseases. J Biol Regul Homeost Agents 1999; 13:14-26.
12. Petitti DB. Statistical methods in meta-analysis. In Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 1994. pp. 90-114.
13. Liu W, Li WM, Yang SS, et al. Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality. Autoimmunity 2006; 39:461-467. (Pubitemid 44575078)
14. Wang Q, Mao H, Gong F, Liao Y, Wang Z, Xiong P. A study of HLA-DRB1 gene polymorphism in dilated cardiomyopathy. J Clin Cardiol (China) 1996; 12:134-136.
15. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against betaadrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64:97-103. (Pubitemid 19028507)
16. Bowles NE, Richardson PJ, Olsen EG, Archard LC. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986; 1:1120-1123.
17. Itagaki T, Yamakawa K, Ono S, et al. Dilated cardiomyopathy associated with natural killer cell deficiency. Am Heart J 1988; 115:1326-1328.
18. Nishi H, Kimura A, Fukuta S, et al. Genetic analysis of dilated cardiomyopathy-HLA and immunoglobulin genes may confer susceptibility. Jpn Circ J 1992; 56:1054-1061. (Pubitemid 23000523)
19. Arbustini E, Gavazzi A, Pozzi R, et al. The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am J Cardiol 1989; 64:991-995. (Pubitemid 19266127)
20. Bender JR. Idiopathic dilated cardiomyopathy. An immunologic, genetic, or infectious disease, or all of the above? Circulation 1991; 83:704-706.
21. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 1991; 83:515-522.
22. Anderson JL, Carlquist JF, Lutz JR, DeWitt CW, Hammond EH. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol 1984; 53:1326-1330. (Pubitemid 14118876)
23. Martinetti M, Dugoujon JM, Caforio AL, et al. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy. Hum Immunol 1992; 35:193-199. (Pubitemid 23019555)
24. Caforio AL, Martinetti M, Schwarz G, et al. Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992; 39:236-240.
25. Jin B, Ni H, Geshang Q, Li Y, Shen W, Shi H. HLA-DR4 antigen and idiopathic dilated cardiomyopathy susceptibility: a meta-analysis involving 11 761 subjects. Tissue Antigens 2011; 77:107-111.
26. Caforio AL, Goldman JH, Baig MK, et al. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail 2001; 3:155-163. (Pubitemid 32216655)
27. Limas C, Limas CJ, Boudoulas H, et al. HLA-DQA1 and -DQB1 gene haplotypes in familial cardiomyopathy. Am J Cardiol 1994; 74:510-512. (Pubitemid 24269979)
28. Zhang X, Wang H, Luo Y, Ji L. HLA-DQ, DR allele polymorphism of type 1 diabetes in the Chinese population: a meta-analysis. Chin Med J 2009; 122:980-986.
29. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res 2001; 56:69-89.
30. Rojas-Villarraga A, Botello-Corzo D, Anaya JM. HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun Rev 2010; 9:666-673.
31. Barcellos LF, May SL, Ramsay PP, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 2009; 5:e1000696.
32. Hashimoto H, Yamanaka K, Tokano Y, et al. HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16:423-427. (Pubitemid 28370853)
33. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1197.
34. Newton-Nash DK, Eckels DD. Differential effect of polymorphism at HLADR1 beta-chain positions 85 and 86 on binding and recognition of DR1- restricted antigenic peptides. J Immunol 1993; 150:1813-1821. (Pubitemid 23129657)
35. Luisetti M, Beretta A, Casali L. Genetic aspects in sarcoidosis. Eur Respir J 2000; 16:768-780.